Evidence map›Paper›PMID 35292814›Full record

ArticleAlcohol and alcoholism (Oxford, Oxfordshire)2022

Service Users' Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists?

Ranjita Dhital, Rachel Coleman, Ed Day, Colin Drummond, Anne Lingford-Hughes, John Marsden, Tom Phillips, Julia Sinclair, John Strang, John Weinman and 3 more

Erratum issuedOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Alcohol and alcoholism (Oxford, Oxfordshire), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Ranjita DhitalUCL Arts and Sciences Department, University College London, London, UK.ORCID 0000-0002-4504-7318
Rachel ColemanAddictions Department, National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Ed DayInstitute for Mental Health, School of Psychology, University of Birmingham and Solihull Integrated Addiction Service, UK.
Colin DrummondAddictions Department, National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Anne Lingford-HughesDivision of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK.
John MarsdenAddictions Department, National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Tom PhillipsAddictions Department, National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.ORCID 0000-0001-8020-4510
Julia SinclairFaculty of Medicine, University of Southampton, Southampton, UK.ORCID 0000-0002-1905-2025
John StrangAddictions Department, National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
John WeinmanSchool of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Cate WhittleseaUCL School of Pharmacy, University College London, London, UK.
Kideshini WidyaratnaAddictions Department, National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Kim DonoghueAddictions Department, National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
King's College London · GBBirmingham and Solihull Mental Health NHS Foundation Trust · GBImperial College London · GBUniversity College London · GBUniversity of Southampton · GB

Funding

Department of Health and Social CareMedical Research Council G0701681Medical Research Council G0701818National Health ServiceNational Institute for Health Research 13/86/03
6 · The paper itself

Abstract

aimsTo understand service users' views and experiences of alcohol relapse prevention medication, views of a telephone behavioural modification intervention delivered by pharmacists and the use of Contingency Management (CM) to support acamprosate adherence following assisted alcohol withdrawal.

methodsFour focus groups were conducted within four alcohol treatment and recovery groups across England (UK), with service users with lived experience of alcohol dependence (26 participants). Semi-structured topic guide was used to explore participants' views and experiences of alcohol relapse prevention medication, a telephone behavioural modification medication intervention delivered by pharmacists, and the use of CM to support acamprosate adherence. These were audio-recorded, transcribed verbatim and thematically analysed inductively and deductively.

resultsFour themes were identified: concerns about support and availability of alcohol relapse prevention medication; lack of knowledge and understanding about acamprosate treatment; positive perceptions of acamprosate adherence telephone support from pharmacists; and negative perceptions of CM to support acamprosate adherence. There were misunderstandings about acamprosate's mode of action and strong negative beliefs about CM. However, most were positive about pharmacists' new role to support acamprosate adherence.

conclusionThis study highlighted challenges service users face to commence alcohol relapse prevention medication. It appears service users could benefit from a pharmacist-led telephone intervention to improve understanding about acamprosate medication, particularly, if delivered in an engaging and motivating way.

Indexed as

AlcoholismCommunity Pharmacy ServicesSubstance Withdrawal SyndromeAcamprosateAttitude of Health PersonnelHumansMedication AdherencePharmacistsProfessional RoleSecondary PreventionAcamprosate

Identifiers

PMID35292814
PMCPMC9465522
OpenAlexW4212899050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.